Cargando…

Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis

BACKGROUND: Progressive familial intrahepatic cholestasis (PFIC) is caused by variations in ATP8B1, ABCB11 or ABCB4 genes. Data on genetic variations in Indian patients with PFIC are lacking. METHODS: Coding and splice regions of the three genes were sequenced in unrelated Indian children with PFIC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Anjali, Poddar, Ujjal, Agnihotry, Shikha, Phadke, Shubha R., Yachha, Surender K., Aggarwal, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032793/
https://www.ncbi.nlm.nih.gov/pubmed/29973134
http://dx.doi.org/10.1186/s12876-018-0835-6
_version_ 1783337572213194752
author Sharma, Anjali
Poddar, Ujjal
Agnihotry, Shikha
Phadke, Shubha R.
Yachha, Surender K.
Aggarwal, Rakesh
author_facet Sharma, Anjali
Poddar, Ujjal
Agnihotry, Shikha
Phadke, Shubha R.
Yachha, Surender K.
Aggarwal, Rakesh
author_sort Sharma, Anjali
collection PubMed
description BACKGROUND: Progressive familial intrahepatic cholestasis (PFIC) is caused by variations in ATP8B1, ABCB11 or ABCB4 genes. Data on genetic variations in Indian patients with PFIC are lacking. METHODS: Coding and splice regions of the three genes were sequenced in unrelated Indian children with PFIC phenotype. The variations identified were looked for in parents, 30 healthy persons and several variation databases, and their effect was assessed in-silico. RESULTS: Among 25 children (aged 1–144 months), nine (36%) had unique major genomic variations (ATP8B1: 4, ABCB11: 3 and ABCB4: 2). Seven had homozygous variations, which were assessed as ‘pathogenic’ or ‘likely pathogenic’. These included: (i) four amino acid substitutions (ATP8B1: c.1660G > A/p.Asp554Asn and c.2941G > A/p.Glu981Lys; ABCB11: c.548 T > C/p.Met183Thr; ABCB4: c.431G > A/p.Arg144Gln); (ii) one 3-nucleotide deletion causing an amino acid deletion (ATP8B1: c.1587_1589delCTT/p.Phe529del); (iii) one single-nucleotide deletion leading to frame-shift and premature termination (ABCB11: c.1360delG/p.Val454Ter); and (iv) a complex inversion of 4 nucleotides with a single-nucleotide insertion leading to frame-shift and premature termination (ATP8B1: c.[589_592inv;592_593insA]/p.Gly197LeufsTer10). Two variations were found in heterozygous form: (i) a splice-site variation likely to cause abnormal splicing (ABCB11: c.784 + 1G > C), and (ii) a nucleotide substitution that created a premature stop codon (ABCB4: c.475C > T/p.Arg159Ter); these were considered as variations of uncertain significance. Three of the nine variations were novel. CONCLUSIONS: Nine major genomic variations, including three novel ones, were identified in nearly one-third  of Indian children with PFIC. No variation was identified in nearly two-thirds of patients, who may have been related to variations in promoter or intronic regions of the three PFIC genes, or in other bile-salt transport genes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-018-0835-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6032793
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60327932018-07-11 Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis Sharma, Anjali Poddar, Ujjal Agnihotry, Shikha Phadke, Shubha R. Yachha, Surender K. Aggarwal, Rakesh BMC Gastroenterol Research Article BACKGROUND: Progressive familial intrahepatic cholestasis (PFIC) is caused by variations in ATP8B1, ABCB11 or ABCB4 genes. Data on genetic variations in Indian patients with PFIC are lacking. METHODS: Coding and splice regions of the three genes were sequenced in unrelated Indian children with PFIC phenotype. The variations identified were looked for in parents, 30 healthy persons and several variation databases, and their effect was assessed in-silico. RESULTS: Among 25 children (aged 1–144 months), nine (36%) had unique major genomic variations (ATP8B1: 4, ABCB11: 3 and ABCB4: 2). Seven had homozygous variations, which were assessed as ‘pathogenic’ or ‘likely pathogenic’. These included: (i) four amino acid substitutions (ATP8B1: c.1660G > A/p.Asp554Asn and c.2941G > A/p.Glu981Lys; ABCB11: c.548 T > C/p.Met183Thr; ABCB4: c.431G > A/p.Arg144Gln); (ii) one 3-nucleotide deletion causing an amino acid deletion (ATP8B1: c.1587_1589delCTT/p.Phe529del); (iii) one single-nucleotide deletion leading to frame-shift and premature termination (ABCB11: c.1360delG/p.Val454Ter); and (iv) a complex inversion of 4 nucleotides with a single-nucleotide insertion leading to frame-shift and premature termination (ATP8B1: c.[589_592inv;592_593insA]/p.Gly197LeufsTer10). Two variations were found in heterozygous form: (i) a splice-site variation likely to cause abnormal splicing (ABCB11: c.784 + 1G > C), and (ii) a nucleotide substitution that created a premature stop codon (ABCB4: c.475C > T/p.Arg159Ter); these were considered as variations of uncertain significance. Three of the nine variations were novel. CONCLUSIONS: Nine major genomic variations, including three novel ones, were identified in nearly one-third  of Indian children with PFIC. No variation was identified in nearly two-thirds of patients, who may have been related to variations in promoter or intronic regions of the three PFIC genes, or in other bile-salt transport genes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-018-0835-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-04 /pmc/articles/PMC6032793/ /pubmed/29973134 http://dx.doi.org/10.1186/s12876-018-0835-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sharma, Anjali
Poddar, Ujjal
Agnihotry, Shikha
Phadke, Shubha R.
Yachha, Surender K.
Aggarwal, Rakesh
Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis
title Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis
title_full Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis
title_fullStr Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis
title_full_unstemmed Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis
title_short Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis
title_sort spectrum of genomic variations in indian patients with progressive familial intrahepatic cholestasis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032793/
https://www.ncbi.nlm.nih.gov/pubmed/29973134
http://dx.doi.org/10.1186/s12876-018-0835-6
work_keys_str_mv AT sharmaanjali spectrumofgenomicvariationsinindianpatientswithprogressivefamilialintrahepaticcholestasis
AT poddarujjal spectrumofgenomicvariationsinindianpatientswithprogressivefamilialintrahepaticcholestasis
AT agnihotryshikha spectrumofgenomicvariationsinindianpatientswithprogressivefamilialintrahepaticcholestasis
AT phadkeshubhar spectrumofgenomicvariationsinindianpatientswithprogressivefamilialintrahepaticcholestasis
AT yachhasurenderk spectrumofgenomicvariationsinindianpatientswithprogressivefamilialintrahepaticcholestasis
AT aggarwalrakesh spectrumofgenomicvariationsinindianpatientswithprogressivefamilialintrahepaticcholestasis